PLSE
NASDAQ HealthcarePulse Biosciences, Inc - Common Stock
Medical Instruments & Supplies
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
๐ Market Data
| Price | $20.83 |
|---|---|
| Volume | 222,647 |
| Market Cap | 1.42B |
| Beta | 1.690 |
| RSI (14-Day) | 58.0 |
| 200-Day MA | $17.19 |
| 50-Day MA | $20.87 |
| 52-Week High | $26.30 |
| 52-Week Low | $12.56 |
| Forward P/E | -24.22 |
| Price / Book | 17.52 |
๐ฏ Investment Strategy Scores
PLSE scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (84/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (9/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find PLSE in your text
Paste any article, transcript, or post โ the tool will extract PLSE and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.